Diffusion-weighted EPI- and HASTE-MRI and 18F-FDG-PET-CT early during chemoradiotherapy in advanced head and neck cancer.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Quantitative Imaging in Medicine and Surgery

• Publication date

  2014-08-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.3978/j.issn.2223-4292.2014.07.15PMID 25202659PMCID PMC4137183
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV

  2013cited by this paper
• Functional imaging to predict treatment response after (chemo) radiotherapy of head and neck squamous cell carcinoma.

  2013cited by this paper
• Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.

  2013cited by this paper
• Diffusion weighted MRI in head-and-neck cancer: geometrical accuracy.

  2013cited by this paper
• Correlation of apparent diffusion coefficients measured by diffusion-weighted MR imaging and standardized uptake values from FDG PET/CT in metastatic neck lymph nodes of head and neck squamous cell carcinomas.

  2012cited by this paper
• Diffusion-Weighted MR Imaging in Head and Neck Cancer: Comparison between Half-Fourier Acquired Single-Shot Turbo Spin-Echo and EPI Techniques

  2012cited by this paper
• FDG PET/CT and Diffusion-Weighted Imaging of Head and Neck Squamous Cell Carcinoma: Comparison of Prognostic Significance Between Primary Tumor Standardized Uptake Value and Apparent Diffusion Coefficient

  2012cited by this paper
• Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?

  2012cited by this paper
• Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla

  2011cited by this paper
• Can 18-FDG-PET during radiotherapy replace post-therapy scanning for detection/demonstration of tumor response in head-and-neck cancer?

  2011cited by this paper
• Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer

  2011cited by this paper
• Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients?

  2010cited by this paper
• PET-CT for response assessment and treatment adaptation in head and neck cancer.

  2010cited by this paper
• Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response

  2010cited by this paper
• Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma

  2010cited by this paper
• Serial FDG-PET on patients with head and neck cancer: Implications for radiation therapy

  2009cited by this paper
• Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck

  2009cited by this paper
• Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.

  2009cited by this paper
• From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

  2009cited by this paper
• A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy.

  2009cited by this paper
• Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.

  2008cited by this paper
• Head and neck cancer

  2008cited by this paper
• Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

  2007cited by this paper
• Diffusion-weighted MRI in the body: applications and challenges in oncology.

  2007cited by this paper
• Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

  2006cited by this paper
• Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial

  2005cited by this paper
• Evaluation of cancer therapy using diffusion magnetic resonance imaging.

  2003cited by this paper
• Basic principles of diffusion-weighted imaging.

  2003cited by this paper
• FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma

  2002cited by this paper
• Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

  2001cited by this paper
• Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

  2000cited by this paper
• Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer.

  1998cited by this paper
• Surgical Morbidity of Neck Dissection after Chemoradiotherapy in Advanced Head and Neck Cancer

  1997cited by this paper
• Head and Neck Cancer

  1993cited by this paper
• Head and neck cancer.

  1991cited by this paper

• DWI-guided DP-IMRT and conventional MRI-based IMRT in head and neck squamous cell carcinoma: a comparative study

  2025cites this paper
• Reirradiation based on diffusion-weighted magnetic resonance imaging-guided dose- painting for locally advanced recurrent nasopharyngeal carcinoma: a phase 2 randomized controlled trial

  2025cites this paper
• The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance

  2024cites this paper
• Comparison of Diffusion-Weighted MRI Using Single-Shot Echo-Planar Imaging and Split Acquisition of Fast Spin-Echo Signal Imaging, a Non-EPI Technique, in Tumors of the Head and Neck

  2024cites this paper
• Interval changes of histogram-derived diffusion indices predict treatment response to induction chemotherapy in head and neck cancer: a feasibility study

  2022cites this paper
• CALIBRATION OF ADC VALUES FOR QUANTITATIVE MRI

  2022cites this paper
• Imaging of human papilloma virus associated oropharyngeal squamous cell carcinoma and its impact on diagnosis, prognostication, and response assessment

  2022cites this paper
• Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive Radiotherapy

  2021cites this paper
• The ability of post-chemoradiotherapy DWI ADCmean and 18F-FDG SUVmax to predict treatment outcomes in head and neck cancer: impact of human papilloma virus oropharyngeal cancer status

  2021cites this paper
• MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?

  2021cites this paper
• Apparent diffusion coefficient agreement and reliability using different region of interest methods for the evaluation of head and neck cancer post chemo-radiotherapy

  2021cites this paper
• Correlations between DW‐MRI and 18F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy

  2021cites this paper
• Diffusion-weighted magnetic resonance imaging (MRI) without susceptibility artifacts: single-shot stimulated echo acquisition mode (STEAM) MRI with iterative reconstruction and spatial regularization.

  2021cites this paper
• Diffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapy

  2020cites this paper
• Correlation between apparent diffusion coefficients and metabolic parameters in hypopharyngeal squamous cell carcinoma: A prospective study with integrated PET/MRI.

  2020cites this paper
• Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review.

  2019cites this paper
• Diffusion-weighted Magnetic Resonance Imaging for Predicting Response to Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma: A Systematic Review

  2019influential citation
• Evaluation of diffusion weighted imaging for tumor delineation in head-and-neck radiotherapy by comparison with automatically segmented 18F-fluorodeoxyglucose positron emission tomography

  2018cites this paper
• The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective.

  2017cites this paper
• Technical Note: Diffusion‐weighted MRI with minimal distortion in head‐and‐neck radiotherapy using a turbo spin echo acquisition method

  2017cites this paper
• Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy.

  2017cites this paper
• Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI

  2017cites this paper
• Interim 18F-FDG PET/CT During Chemoradiation Therapy in the Management of Head and Neck Cancer Patients: A Systematic Review.

  2017cites this paper
• Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up

  2017cites this paper
• Assessment of serial multi-parametric functional MRI (diffusion-weighted imaging and R2*) with (18)F-FDG-PET in patients with head and neck cancer treated with radiation therapy.

  2016cites this paper
• Assessment of serial multi-parametric functional MRI (diffusion-weighted imaging and R 2 *) with 18 F-FDG-PET in patients with head and neck cancer treated with radiation therapy

  2016cites this paper
• Use of diffusion-weighted magnetic resonance imaging (DW-MRI) to investigate the effect of chemoradiotherapy on the salivary glands

  2015cites this paper
• PET/MR in cancers of the head and neck.

  2015cites this paper
• Novel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients.

  2015cites this paper